Prescription drug price transparency

The following resources are for reporting entities who may need assistance with prescription drug price transparency.

On this page

Want to stay up-to-date on prescription drug price transparency?

Sign up for notifications

Reporting entity resources (carriers, manufacturers, PBMs, PSAOs)

The following resources are for reporting entities who may need assistance.

The excel templates below are available as an aid if you are hand-keying data for submissions to the Drug Price Transparency program. These workbooks are programmed with simple rules that will help you avoid some common errors that can occur.

Important note about Excel version

We recommend using Microsoft Excel 2016 or earlier for the submission guides. Using Microsoft Excel 2019 can cause formatting issues when saving as a CSV file.

DPT login process

Starting November 15, reporting entities can log into HCA Support to enter their data for the DPT program. You will need a SecureAccess Washington (SAW) account to login.

Setting up a SAW account

Step-by-step instructions for accessing DPT reporting forms

Extensions

Use the extension form if you are not able to meet the due date of a required report and would like to request additional time. To access the extension form, follow the instructions for accessing DPT reporting forms. Once you have accessed the portal, you will see the DPT re-submission/extension option.

All

Carriers

Report year 2023 (effective September 1, 2024)

Manufacturers

Report year 2024

Effective January 1, 2024

Pharmacy Benefit Managers (PBM)

Report year 2022 (due date March 1, 2024)

Report year 2021

Pharmacy Services Administrative Organizations (PSAOs)

Report year 2023 (effective September 1, 2024)

Report year 2022 (effective until August 31, 2024)

Report year 2021 (effective until August 31, 2023)

Stakeholder meetings

At each meeting, HCA will give a short overview of Chapter 43.71C RCW then use the majority of time to take questions and hear concerns from stakeholders. We will focus on a different supplier in each meeting. The public is invited to participate in any of the meetings.

Meeting schedule

Date and time Meeting type Materials
July 28, 2021 PBM listening session

Slide deck

Listening session audio
July 22, 2021 Manufacturer listening session

Slide deck

Listening session audio
July 6, 2021 Carrier listening session

Slide deck

Listening session audio
April 29, 2020

Pharmacy benefit manager / pharmacy service administrative organization reporting

Webinar only, no in person meeting due to COVID-19

Slide deck

Recorded webinar
April 1, 2020

Issuer / carrier reporting

Webinar only, no in person meeting due to COVID-19

 Updated slide deck

Recorded webinar
February 26, 2020 Manufacturer reporting

Slide deck

Recorded webinar

Background

In 2019, the Washington State Legislature passed Engrossed Second Substitute House Bill into law. This law requires issuers of health insurance, pharmacy benefit managers (PBMs), manufacturers, and pharmacy service administrative organizations (PSAOs) to submit data to the Health Care Authority (HCA). The purpose is to create an annual report on how prescription drugs affect health care costs. The law also requires pharmaceutical manufacturers to submit data to HCA relating the new drug applications (NDA).

Reports

Annual reports created by HCA to detail the current state of the program as the agency begins to receive drug pricing and cost data.

Contact

Program questions and information
Email: HCA Drug Price Transparency - general inquiry

Technical data related questions, or any questions regarding the data submission process
Email: HCA Drug Price Transparency - tech support

Protections for insurance consumers and insurance industry oversight
Contact: Washington State Office of the Insurance Commissioner (OIC)